TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q1 2023 Earnings Call Transcript May 10, 2023
TRACON Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.36 EPS, expectations were $-0.26.
Operator: Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals First Quarter 2023 Earnings Conference Call. [Operator Instructions]. During today’s call, we will be making certain forward-looking statements, including statements regarding expected timing of clinical trials...
